Articles related to ALZHEIMER'S/DEMENTIA

Zunveyl, a prodrug of galantamine, has been formulated to minimize gastrointestinal absorption, potentially addressing common tolerability issues associated with acetylcholinesterase inhibitors in Alzheimer’s treatment.

LANS presents with memory symptoms that mimic Alzheimer’s disease, but brain imaging and biomarkers indicate a different underlying condition, potentially leading to more accurate diagnoses and prognoses for older adults with cognitive decline.

Kisunla’s approval introduces a novel treatment option for early Alzheimer’s disease, potentially altering the landscape of AD management with its ability to significantly reduce amyloid plaque levels and slow cognitive decline.

Recent research suggests that promoting neuroplasticity through various techniques may offer new treatment possibilities for patients with neurodegenerative diseases, developmental disorders, and mental health conditions.

Incorporating at least 7 grams of olive oil daily may reduce dementia-related death risk by 28%, offering a practical dietary recommendation for cognitive health.

Increased daily olive oil consumption is associated with a 28% lower risk of dementia-related mortality, providing potential cognitive health benefits even after adjusting for genetic risk factors.